#Delta4
dude playing delta4 while high is making me tweak the fuck out
November 9, 2026 at 5:07 AM
𝐁𝐢𝐨𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐚𝐭𝐚 -> 𝐂𝐨𝐧𝐧𝐞𝐜𝐭 𝐭𝐡𝐞 𝐝𝐨𝐭𝐬.
Our Hyper-KG biomedical knowledge graph connects entities & relationships across diseases, drugs, targets, biomarkers & biological mechanisms.
Because in drug discovery, understanding individual components & how they relate is essential.
delta4.ai/hyper-c/
November 10, 2026 at 11:02 AM
Last week in Berlin: Delta4 was proud to be a Gold Sponsor of Agile Falcon's Drug Discovery Strategic Summit (DDSS).

Biological modelling emerged as a recurring theme, alongside insightful discussions on the evolving needs of Big Pharma.

#DrugDiscovery #ComputationalBiology #PharmaInnovation
November 4, 2026 at 12:35 PM
September was Prostate Cancer Awareness Month.
A new Nature study analyzed the genomes of 959 prostate cancer donors and identified 8 integrated mutational footprints, 4 of which were linked to shorter time to metastasis.
Our blog looks at synthetic lethality:
👉 delta4.ai/synthetic-le...
#Delta4
October 13, 2026 at 10:20 AM
EcoFlow、園芸・アウトドア展示会「GARDEX」に出展 – 新製品「DELTA 4」シリーズを実機展示
#GARDEX #DELTA4 #第20回国際ガーデンアウトドアEXPO #ITニュース
ITちゃんねる
EcoFlow、園芸・アウトドア展示会「GARDEX」に出展 – 新製品「DELTA 4」シリーズを実機展示 #GARDEX #DELTA4 #第20回国際ガーデンアウトドアEXPO #ITニュース
it.f-frontier.com
October 6, 2026 at 2:28 AM
We’re pleased to share that Paul, Delta4's Computational Biology Lead, is representing Austria as a Management Committee member in the new COST Action CA25128, #KidneyHealth.

A natural continuation of our work in computational and systems biology for CKD.

#CKD #ComputationalBiology #D4 #COSTAction
October 5, 2026 at 12:09 PM
The -other- participants of the study:

@manuelkleiner.bsky.social
@grubervodicka.bsky.social
@vollandlab.bsky.social
@nicoledubilier.bsky.social
Christer Erséus
Nikolaus Leisch
Bruno Huettel
Cecilia Wentrup
Tanja Woyke
Juliane Wippler

Research paper is published on Science Advances.
October 3, 2026 at 4:39 AM
❤️𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐚𝐫𝐭 𝐃𝐚𝐲

For a long time, cardiovascular disease, kidney disease, obesity and diabetes have been approached as separate problems. The emerging concept of 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫–𝐤𝐢𝐝𝐧𝐞𝐲–𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 (𝐂𝐊𝐌) 𝐡𝐞𝐚𝐥𝐭𝐡 brings these systems together.

For us at #Delta4, this systems-level perspective matters.
September 29, 2026 at 8:26 AM
Last year, we swapped laptops for lawn chairs.

This year, we needed more lawn chairs than ever. 😄

There were more of us to fill them at our biggest Delta4 BBQ yet!

Good food, good company, and a well-earned afternoon away from our screens. ☀️🌭

#Delta4 #TeamDelta4 #SummerBBQ
September 7, 2026 at 11:29 AM
Delta4’s use of data-driven insights in pharmaceutical design is compelling. AI can streamline discovery, but real-world validation across diverse cohorts remains key. Stay tuned for clinical proof beyond the patent buzz.
March 24, 2025 at 12:16 PM
Uber's early growth hack was giving free rides to tech influencers at events like SXSW, ensuring the most connected people experienced a product so good they couldn't stop talking about it. 👇 #Delta4 #Startups #Growth #Technology
September 1, 2025 at 8:28 AM
I wonder what would happen if you sent off this tear-out page from the 1999 edition of the Delta IV Payload Planner's Guide today. Realistically speaking I suppose probably nothing, but it's a little bit funny to think about.
April 28, 2025 at 12:09 AM
What is it like to work with Delta4?

Across nephrology, oncology, neuroimmunology & beyond, our partners highlight scientific rigor, computational expertise and our ability to turn complex biomedical data into actionable insights.

See what others say: delta4.ai/services/

#DrugDiscovery
August 18, 2026 at 7:16 AM
Delta4’s AI drug discovery engine is available directly on a global life science marketplace, making it easier for pharma and biotech teams to explore new indications and drug repositioning opportunities with Hyper‑C.

🔗 Discover more in a blog by Scientist.com: www.scientist.com/blog/acceler...
August 10, 2026 at 10:20 AM
Finding the right #compounds for the right #diseases is a key challenge in #DrugRepositioning. Delta4’s Hyper-C platform starts with disease biology to identify promising therapeutic opportunities and provides mechanistic rationales to support development decisions.
Read more: delta4.ai/services/
August 4, 2026 at 11:35 AM
Many diseases require more than a single #therapeutic approach. With the support of #Combo-C, we identify and evaluate promising #DrugCombinations, providing the biological rationale behind each prediction—helping pharma prioritize candidates before the lab.
Explore: delta4.ai/services/
#Delta4
July 29, 2026 at 11:28 AM
#SyntheticLethality is not only about new targets — it’s about treating the right patients in the right way.
With Hyper-C, Delta4 connects multi-omics data to prioritize synthetic lethal interactions and enable smarter patient selection and trial design. Read more:
🔗 delta4.ai/synthetic-lethality
July 16, 2026 at 11:20 AM
Diseases are rarely driven by a single pathway. Drugs rarely act on a single mechanism.
By integrating diverse biological data into a unified framework, the Hyper-C platform helps identify connections that may otherwise remain hidden.

Explore: delta4.ai/hyper-c/

#DrugDiscovery #AI #SystemsBiology
June 22, 2026 at 3:33 PM
#Synthetic lethality is a promising concept in precision oncology, but discovery remains the bottleneck. With ~20,000 genes, the number of possible interactions is enormous. Most remain unmapped, but computational approaches can help narrow the space. ➡️https://delta4.ai/synthetic-lethality
#Oncology
June 16, 2026 at 10:20 AM
The FDA is encouraging drug repurposing—finding new uses for existing drugs in areas of unmet need. At Delta4, we extend this to drug combinations, aiming to identify synergistic, multi-target strategies for complex diseases.
#DrugRepurposing #SystemsBiology #PrecisionMedicine
May 22, 2026 at 12:05 PM
#Delta4's Enrico presented his poster at the #YSA Symposium 2026 at the Medical University of Vienna. His work on systems-biological modeling of the #AKI-to-#CKD transition was selected for Session V (Regeneration & Transplantation) and sparked lively scientific discussion.
#TranslationalResearch
May 18, 2026 at 9:30 AM
Diseases like #ADPKD and #FSGS are driven by complex, interconnected biological networks.

What if the key to better therapies lies not in one target — but in understanding the system?

At Delta4, we advocate for a shift towards network-based approaches in #drugDiscovery.

#systemsbiology #techbio
April 28, 2026 at 7:34 AM